Home/Filings/4/0002039294-26-000002
4//SEC Filing

Cowan Chad 4

Accession 0002039294-26-000002

CIK 0001850119other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:10 PM ET

Size

5.9 KB

Accession

0002039294-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Cowan Chad
Chief Scientific Officer
Transactions
  • Tax Payment

    Common Stock

    2026-01-02$0.99/sh1,611$1,6031,043,476 total
Holdings
  • Common Stock

    (indirect: By Trust)
    10,697
Footnotes (2)
  • [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Issuer

Century Therapeutics, Inc.

CIK 0001850119

Entity typeother

Related Parties

1
  • filerCIK 0002039294

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:10 PM ET
Size
5.9 KB